AI Article Synopsis

  • Asthma is a complex condition marked by chronic inflammation in the airways, reversible airflow issues, and structural changes in the airways, with eosinophil peroxidase (EPX) being a key protein involved.
  • The study found that higher levels of EPX and ADAM33 in asthma patients are associated with poorer lung function and increased levels of the inflammatory marker IL-5.
  • EPX promotes changes in airway cells (known as epithelial-mesenchymal transition) that contribute to asthma symptoms, and inhibiting a specific pathway (PI3K) can enhance the understanding of EPX's role, potentially leading to new treatments for airway remodeling in asthma.

Article Abstract

Asthma is a heterogeneous disease characterized by chronic airway inflammation, reversible airflow limitation, and airway remodeling. Eosinophil peroxidase (EPX) is the most abundant secondary granule protein unique to activated eosinophils. In this study, we aimed to illustrate the effect of EPX on the epithelial-mesenchymal transition (EMT) in BEAS-2B cells. Our research found that both EPX and ADAM33 were negatively correlated with FEV1/FVC and FEV1%pred, and positively correlated with IL-5 levels. Asthma patients had relatively higher levels of ADAM33 and EPX compared to the healthy control group. The expression of TSLP, TGF-β1 and ADAM33 in the EPX intervention group was significantly higher. Moreover, EPX could promote the proliferation, migration and EMT of BEAS-2B cells, and the effect of EPX on various factors was significantly improved by the PI3K inhibitor LY294002. The findings from this study could potentially offer a novel therapeutic target for addressing airway remodeling in bronchial asthma, particularly focusing on EMT.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2024.110228DOI Listing

Publication Analysis

Top Keywords

airway remodeling
12
eosinophil peroxidase
8
emt beas-2b
8
beas-2b cells
8
cells epx
8
adam33 epx
8
epx
7
peroxidase promotes
4
promotes bronchial
4
bronchial epithelial
4

Similar Publications

The Mechanisms and Therapeutic Implications of PI3K Signaling in Airway Inflammation and Remodeling in Asthma.

Biologics

March 2025

Key Laboratory of Dunhuang Medicine and Transformation, Ministry of Education, Gansu, People's Republic of China.

Bronchial asthma is a complex and heterogeneous disease with ongoing airway inflammation and increased airway responsiveness. Key characteristics of the disease include persistent airway inflammation, airway hyperresponsiveness, and airway remodeling. Asthma's chronic and recurrent characteristics contribute to airway remodeling and inflammation, which can exacerbate lung damage.

View Article and Find Full Text PDF

Asthma is a chronic respiratory condition characterized by airway inflammation, remodeling, and hyperresponsiveness to triggers causing airway constriction. Bronchial smooth muscle plays a critical role by narrowing airways, leading to obstruction and breathing difficulties, often exacerbated by mast cell infiltration and histamine release. Whereas current treatments, including bronchodilators, corticosteroids, and biologics provide effective management for most patients, alternative therapies are needed for difficult-to-treat asthma.

View Article and Find Full Text PDF

Asthma is a chronic lung disease that occurs repeatedly and is hardly cured. Clinical studies have shown that acupuncture can effectively relieve asthma-related symptoms and is an ideal measure to treat asthma. The paper reviews the clinical and mechanism researches of acupuncture for asthma reported in China and other countries in recent 5 years, so as to provide the relevant evidences for the further study on asthma.

View Article and Find Full Text PDF

Objectives: To observe the effect of acupuncture at "Dazhui" (GV14) and "Shenzhu" (GV12) on DEK/phosphorylated phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway and epithelial-mesenchymal transition related factors in rats with allergic asthma (AA), so as to explore its potential mechanism in the treatment of AA.

Methods: Sixty SD rats were randomly divided into normal, model, acupuncture, dexamethasone (DEX) and sham-acupuncture groups, with 12 rats in each group. The AA model was made by intraperitoneal injection of mixture solution of ovalbumin and aluminium hydroxide gel (on day 1 and 7) and followed by inhalation of atomized 1% ovalbumin (30 min, from day 15, once daily for 14 days).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!